Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2013 Financial Results

[PR Newswire] – SAN DIEGO, Feb. 28, 2014 /PRNewswire/ — Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary products … more

View todays social media effects on CADX

View the latest stocks trending across Twitter. Click to view dashboard

See who Cadence is hiring next, click here to view